CHE today
$550.62+$6.13 (+1.13%)close Nov 11, 2026Trend
DailyUptrend (confirmed)
4 hourSymmetric Triangle
1 hourBullish
15 minBullish
5 minConsolidating
Daily trend turns down below $494.29
Key levels
Resistance$581.20
Resistance$562.24
Support$545.79
Support$521.65
Latest news & SEC filings
NewsChemed board approves 70-cent quarterly payout to shareholders
SEC FilingChemed Corp filed an insider trading report (Form 4)
All CHE news →About Chemed
Chemed runs two main businesses. VITAS delivers end-of-life and comfort-focused medical care using doctors, nurses, aides, social workers, and volunteers. Roto-Rooter handles pipe and sewer work, drain clearing, digging, and water damage repair for homes and businesses. VITAS mostly treats Medicare recipients, while Roto-Rooter serves residential and commercial clients, primarily in the United States.
Based on the company's 10-K filed Feb 27, 2026.
NYSE · Healthcare
CHEMED CORP (CHE)
What Is the Price Target for CHE?
SEPT Low Target
$510.00
SEPT Mid Target
$620.00
SEPT High Target
$675.00
Analyst Consensus
$620.00
Is CHE a Buy or Sell Right Now?
Thesis
- •Revenue growing 4.1% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CHE.
Start Free Trial →Is CHE Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$516.62
45
Moat Score
NARROW
5/9
Piotroski Score
13.5
Altman Z-Score
What Is Smart Money Doing with CHE?
Insider Signal
SELLING
0 buys / 7 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| MCNAMARA KEVIN J | director officer | Sale | 2,000 | $1.1M | Nov 3, 2026 |
| LEE SPENCER S | officer | Sale | 920 | $494K | Nov 2, 2026 |
| LEE SPENCER S | officer | Buy | 12,099 | $5.4M | Sep 30, 2026 |
| LEE SPENCER S | officer | Sale | 11,160 | $5.7M | Sep 30, 2026 |
| HUTTON THOMAS C | director officer | Buy | 4,629 | $2.1M | Sep 28, 2026 |
| HUTTON THOMAS C | director officer | Sale | 4,270 | $2.2M | Sep 28, 2026 |
| MCNAMARA KEVIN J | director officer | Sale | 2,000 | $1.0M | Sep 28, 2026 |
| MCNAMARA KEVIN J | director officer | Sale | 2,000 | $1.0M | Sep 18, 2026 |
| LINDELL ANDREA R | director | Sale | 1,347 | $603K | Jun 9, 2026 |
| WALSH GEORGE J III | director | Sale | 500 | $219K | May 29, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CHE Growth Story
Revenue YoY
4.1%
3yr Revenue CAGR
5.8%
EPS Growth YoY
-7.79%
FCF Growth YoY
-11.6%
Revenue Trend
STABLE
Dark Pool Trades for CHE
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CHE, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:25:08 | $550.62 | 48,095 | $$26.5M | BUY |
| 21:00:25 | $550.62 | 5,797 | $$3.2M | SELL |
| 22:41:31 | $538.06 | 6,040 | $$3.2M | BUY |
| 21:04:55 | $538.06 | 1,369 | $$737K | BUY |
| 21:00:36 | $538.06 | 2,140 | $$1.2M | BUY |
5 dark pool trades shown · $$34.8M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for CHEMED CORP (CHE) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CHE — frequently asked questions
What is CHE stock price today?
CHEMED CORP (CHE) is at $550.62, up 1.13% (+$6.13) at the Nov 11, 2026 close.
Why is CHE stock moving today?
Latest CHE news — Nov 6, 2026: Chemed board approves 70-cent quarterly payout to shareholders · Nov 5, 2026: Chemed Corp filed an insider trading report (Form 4)
What is the CHE price target?
The average analyst price target for CHE is $620.00, ranging from $510 to $675, based on 5 analysts. Latest: RBC Capital maintains on Oct 29, 2026.
What do analysts rate CHE?
Analyst ratings for CHE: 3 Buy, 7 Hold, 0 Sell — consensus Hold.
Did CHE beat earnings?
CHE last reported on Oct 27, 2026: EPS $6.75 vs $6.39 expected — a beat of 5.6%.
What is CHE's P/E ratio?
CHE trades at a P/E of 25.6 vs a Healthcare average of 17.7.
Does CHE pay a dividend?
Yes. CHE's dividend yield is 0.51%.
What are CHE support and resistance levels?
Support: $545.79, $521.65, $494.29. Resistance: $562.24, $581.20, $604.91.
What are insiders doing with CHE?
Insider activity: SELLING, 0 buys and 7 sells in the last 90 days.
What is the latest news on CHE?
Nov 6, 2026: Chemed board approves 70-cent quarterly payout to shareholders · Nov 5, 2026: Chemed Corp filed an insider trading report (Form 4)